Menu

Report Library

All Reports
Datamonitor Healthcare Oncology: Myelofibrosis Market Spotlight

January 10, 2023

Myelofibrosis is a myeloproliferative neoplasm which can exist as a primary disease known as primary myelofibrosis, or can evolve to post-polycythemia vera (PV) or post-essential thrombocythemia (ET) myelofibrosis from PV or ET. It is characterized by the buildup of scar tissue (fibrosis) in bone marrow, which leads to a reduction in blood cell production. 

This Datamonitor Healthcare report contains a Market Spotlight module.

Indications Covered: Myelofibrosis (MF)
Back to the top Back to the top